Skip to content

FIRST CHINA PHARMACEUTICAL GROUP, INC.

CIK 0001432254

← back to feed
Revenue (TTM)
$57.83M
+61.4% YoY Q3 Nov 2012
Net Income (TTM)
$2.96M
+495.2% YoY Q3 Nov 2012
EPS Diluted (TTM)
$0.05
+386.8% YoY Q3 Nov 2012
Gross Margin
9.2%
Q3 Nov 2012
Operating Margin
5.4%
Q3 Nov 2012
Net Margin
5.1%
Q3 Nov 2012
Free Cash Flow (TTM)
$2.29M
Q3 Nov 2012
Cash
$6.4M
Q3 Nov 2012
Total Debt
$3.26M
Q3 Nov 2012
Shares Outstanding
59.66M sh
Q3 Nov 2012

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings